Mydecine Innovations Group (NEOE:MYCO) Short-Term Capital Lease Obligation : C$0.00 Mil (As of Sep. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Mydecine Innovations Group Short-Term Capital Lease Obligation?

Mydecine Innovations Group's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$0.00 Mil.

Mydecine Innovations Group's annual Short-Term Capital Lease Obligation increased from Dec. 2020 (C$0.07 Mil) to Dec. 2021 (C$0.08 Mil) but then declined from Dec. 2021 (C$0.08 Mil) to Dec. 2022 (C$0.00 Mil).

Mydecine Innovations Group Short-Term Capital Lease Obligation Historical Data

The historical data trend for Mydecine Innovations Group's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Short-Term Capital Lease Obligation Chart

Mydecine Innovations Group Annual Data

Trend

Dec13

Aug14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.04

0.07

0.08

Mydecine Innovations Group Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	-	-

Mydecine Innovations Group Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Mydecine Innovations Group Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Mydecine Innovations Group (NEOE:MYCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (NEOE:MYCO) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

MYCOF:USA 0NF0:Germany MYCO:Canada

Address

789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2

Website

https://www.mydecine.com

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (NEOE:MYCO) Headlines

No Headlines